Sources | Names Used |
---|---|
CTRPv2 | BRD-K27188169:navitoclax (2:1 mol/mol) |
PharmacoGx | BRD-K27188169:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SDR39U1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
mRNA | CAMTA1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | CTSW | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | HPCAL4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | SEMA4B | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
mRNA | NDUFAF5 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | PIH1D1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
mRNA | CTNNBL1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | CABLES2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | CHMP5 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |